SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge by Steve Jones January 22, 2025January 22, 2025 The number of medicinal cannabis approvals through the Special Access Scheme jumped almost 40% in 2024, […]
Pastilles continue steady SAS-B growth but flower retains top spot by Steve Jones December 4, 2024April 11, 2025
SAS-B deep dive: half-year data illustrates shifting sands as monthly approvals hit almost 20,000 by Steve Jones July 3, 2024July 3, 2024
SAS-B surge continues in March bringing Q1 total to record high by Martin Lane April 2, 2024July 16, 2024
Victoria regains top spot as SAS-B approvals surge in February by Martin Lane March 6, 2024November 25, 2024
SAS-B data shows strong start to 2024 with QLD and high-THC approvals dominating by Martin Lane February 12, 2024July 16, 2024
Queensland regains top spot as SAS-B 2023 total surpasses previous high by Steve Jones December 7, 2023April 30, 2024
